Dr. Mothaffar Rimawi, MD
Claim this profileBaylor College of Medicine
Studies Breast Cancer
Studies Breast cancer
11 reported clinical trials
23 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
Stage IV
2Breast Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Mothaffar Rimawi, MD is currently running
Chemotherapy Response Prediction
for Breast Cancer
The purpose of this study is to learn whether clinical response (the amount a tumor shrinks based on imaging or tumor measurements obtained by physical exam) predicts pathologic response (the amount of tumor remaining when surgery is performed) in participants with breast cancer who are receiving chemotherapy prior to surgery.
Recruiting1 award Phase 2
Ruxolitinib
for Precancerous Breast Conditions
This trial is testing if ruxolitinib can change early abnormal breast cells that might turn into cancer. Some participants will take the drug for a short period, while others will not. Afterward, all participants will have surgery to remove the abnormal cells. Ruxolitinib has been evaluated in various clinical trials for treating certain types of breast cancer.
Recruiting0 awards Phase 28 criteria
More about Mothaffar Rimawi, MD
Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Mothaffar Rimawi, MD has experience with
- Paclitaxel
- Pertuzumab
- Trastuzumab
- Placebo
- Tucatinib
- GLSI-100
Breakdown of trials Mothaffar Rimawi, MD has run
Breast Cancer
Breast cancer
Lobular Carcinoma in Situ
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mothaffar Rimawi, MD specialize in?
Mothaffar Rimawi, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Mothaffar Rimawi, MD currently recruiting for clinical trials?
Yes, Mothaffar Rimawi, MD is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Mothaffar Rimawi, MD has studied deeply?
Yes, Mothaffar Rimawi, MD has studied treatments such as Paclitaxel, Pertuzumab, Trastuzumab.
What is the best way to schedule an appointment with Mothaffar Rimawi, MD?
Apply for one of the trials that Mothaffar Rimawi, MD is conducting.
What is the office address of Mothaffar Rimawi, MD?
The office of Mothaffar Rimawi, MD is located at: Baylor College of Medicine, Houston, Texas 77057 United States. This is the address for their practice at the Baylor College of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.